Table 3.
Acute episode | Maintenance | |||
Medication | Mania | Depression | Mixed | |
Mood stabilizers | ||||
Lithium | M, C | X | M, C | |
Divalproex, divalproex ER | M, C | X | X | |
Carbamazepine, carbamazepine ER | M, C | M, C | ||
Lamotrigine | X | M, C | ||
Atypical antipsychotics | ||||
Aripiprazole | M, A | M, A | M, A | |
Asenapine | M, A | M, A | ||
Lurasidone | M (BP I) | |||
Olanzapine | M, A | C (with fluoxetine, BP I) | M, A | M* |
Quetiapine IR, XR | M, A | M (BP I and II) | M, A (only XR) | A |
Risperidone | M, A | M, A | M, A (only RLAI) | |
Ziprasidone | M* | M* | A |
*Also used adjunctively but not FDA indicated.
A, adjunctive to a mood stabilizer; C, combination therapy with another mood stabilizer, antipsychotic, or antidepressant; M, monotherapy; RLAI risperidone long‐acting injectable; X, recommended in guidelines but not FDA indicated.